Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 947-950

  Murray, Robert W ^a   Schaadt, Ronda D ^a   Zurenko, Gary E ^a   Marotti, Keith R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN; EPEREZOLID; ERYTHROMYCIN; GENTAMICIN; LINCOMYCIN; OXACILLIN; OXAZOLIDINONE DERIVATIVE; STREPTOMYCIN; TETRACYCLINE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CELL FREE SYSTEM; GENETIC SUSCEPTIBILITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE; PRIORITY JOURNAL; RIBOSOME SUBUNIT; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0031956779     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.947     Document Type: Note

References (22)

1. Barbachyn, M. R., D. K. Hutchinson, S. J. Brickner, M. H. Cynamon, O. J. Kilburn, S. P. Klemens, S. E. Glickman, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. 39:680-685.
2. Barry, A. L. 1988. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents. Antimicrob. Agents Chemother. 32:150-152.
3. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulanowicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679.
4. Brumfitt, W., and J. M. T. Hamilton-Miller. 1992. Antibacterial oxazolidinones: in vitro activity of a new analogue, E3709. Diagn. Microbiol. Infect. Dis. 15:621-625.
5. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering. 1988. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. Antimicrob. Agents Chemother. 21:721-730.
6. Daly, J. S., G. M. Eliopoulos, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
7. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
8. Eustice, D. C., P. A. Feldman, A. M. Slee. 1988. The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
9. Fernandez-Munoz, R., R. E. Monro, and D. Vazquez. 1971. Ribosomal peptidyltransferase: binding of inhibitors. Methods Enzymol. 20:481-490.
10. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
11. Lelong, J. C., M. Grunberg-Manago, J. Dondon, D. Gros, and F. Gros. 1970. Interaction between guanosine derivatives and factors involved in the initiation of protein synthesis. Nature 226:505-510.
12. Lin, A. H., R. W. Murray, T. J. Vidmar, and K. R. Marotti. 1997. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with the binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. 41:2127-2131.
13. Mahmood, R., P. Compagnone-Post, and S. A. Khan. 1991. An in vitro coupled transcription-translation system from Staphylococcus aureus. Gene 106:29-34.
14. Mini, E., A. Novelli, T. Mazzei, and P. Periti. 1989. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against Staphylococci and Streptococci. Eur. J. Clin. Microbiol. Infect. Dis. 8:256-260.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Noller, H. F. 1991. Ribosomal RNA and translation. Annu. Rev. Biochem. 60:191-227.
17. 16a. Shinabarger, D. L., K. R. Marotti, R. W. Murray, A. H. Lin, E. P. Melchior, S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Busse. 1997. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41:2132-2136.
18. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawads, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother. 31:1791-1797.
19. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
20. Stallcup, M. R., and J. C. Rabinowitz. 1973. Initiation of protein synthesis in vitro by a clostridial system: specificity in the translation of natural messenger ribonucleic acids. J. Biol. Chem. 248:3209-3215.
21. Wada, A., H. Ohta, K. Kulthanan, and K. Hiramatsu. 1993. Molecular cloning and mapping of 16S-23S rRNA gene complexes of Staphylococcus aureus. J. Bacteriol. 175:7483-7487.
22. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. K. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.